OBJECTIVES: Existing data support a modest association between cigarette smoking and incident colorectal cancer (CRC) overall. In this study, we evaluated associations between cigarette smoking and CRC risk stratified by KRAS mutation status, using data and tissue resources from the Iowa Women's Health Study (IWHS). METHODS: The IWHS is a population-based cohort study of cancer incidence among 41,836 randomly selected Iowa women, ages 55-69 years of age at enrollment (1986). Exposure data, including cigarette smoking, were obtained by self-report at baseline. Incident CRCs (n=1,233) were ascertained by annual linkage with the Iowa Cancer Registry. Archived tissue specimens from CRC cases recorded through 2002 were recently requested for molecular epidemiology investigations. Tumor KRAS mutation status was determined by direct sequencing of exon 2, with informative results in 507/555 (91%) available CRC cases (342 mutation negative and 165 mutation positive). Multivariate Cox regression models were fit to estimate relative risks (RRs) and 95% confidence intervals (CIs) for associations between cigarette smoking variables and KRAS-defined CRC subtypes. RESULTS: Multiple smoking variables were associated with increased risk for KRAS mutation-negative tumors, including age at initiation (P=0.02), average number of cigarettes per day (P=0.01), cumulative pack-years (P=0.05), and induction period (P=0.04), with the highest point estimate observed for women who smoked ≥40 cigarettes per day on average (RR=2.38; 95% CI=1.25-4.51; compared with never smokers). Further consideration of CRC subsite suggested that cigarette smoking may be a stronger risk factor for KRAS mutation-negative tumors located in the proximal colon than in the distal colorectum. None of the smoking variables were significantly associated with KRAS mutation-positive CRCs (overall or stratified by anatomic subsite). CONCLUSIONS: Data from this prospective study of older women demonstrate differential associations between cigarette smoking and CRC subtypes defined by KRAS mutation status, and are consistent with the hypothesis that smoking adversely affects the serrated pathway of colorectal carcinogenesis.
OBJECTIVES: Existing data support a modest association between cigarette smoking and incident colorectal cancer (CRC) overall. In this study, we evaluated associations between cigarette smoking and CRC risk stratified by KRAS mutation status, using data and tissue resources from the Iowa Women's Health Study (IWHS). METHODS: The IWHS is a population-based cohort study of cancer incidence among 41,836 randomly selected Iowa women, ages 55-69 years of age at enrollment (1986). Exposure data, including cigarette smoking, were obtained by self-report at baseline. Incident CRCs (n=1,233) were ascertained by annual linkage with the Iowa Cancer Registry. Archived tissue specimens from CRC cases recorded through 2002 were recently requested for molecular epidemiology investigations. TumorKRAS mutation status was determined by direct sequencing of exon 2, with informative results in 507/555 (91%) available CRC cases (342 mutation negative and 165 mutation positive). Multivariate Cox regression models were fit to estimate relative risks (RRs) and 95% confidence intervals (CIs) for associations between cigarette smoking variables and KRAS-defined CRC subtypes. RESULTS: Multiple smoking variables were associated with increased risk for KRAS mutation-negative tumors, including age at initiation (P=0.02), average number of cigarettes per day (P=0.01), cumulative pack-years (P=0.05), and induction period (P=0.04), with the highest point estimate observed for women who smoked ≥40 cigarettes per day on average (RR=2.38; 95% CI=1.25-4.51; compared with never smokers). Further consideration of CRC subsite suggested that cigarette smoking may be a stronger risk factor for KRAS mutation-negative tumors located in the proximal colon than in the distal colorectum. None of the smoking variables were significantly associated with KRAS mutation-positive CRCs (overall or stratified by anatomic subsite). CONCLUSIONS: Data from this prospective study of older women demonstrate differential associations between cigarette smoking and CRC subtypes defined by KRAS mutation status, and are consistent with the hypothesis that smoking adversely affects the serrated pathway of colorectal carcinogenesis.
Authors: E Van Cutsem; M Dicato; N Arber; J Berlin; A Cervantes; F Ciardiello; A De Gramont; E Diaz-Rubio; M Ducreux; R Geva; B Glimelius; R Glynne Jones; A Grothey; T Gruenberger; D Haller; K Haustermans; R Labianca; H J Lenz; B Minsky; B Nordlinger; A Ohtsu; N Pavlidis; P Rougier; W Schmiegel; C Van de Velde; H J Schmoll; A Sobrero; J Tabernero Journal: Ann Oncol Date: 2010-06 Impact factor: 32.976
Authors: M E Martínez; T Maltzman; J R Marshall; J Einspahr; M E Reid; R Sampliner; D J Ahnen; S R Hamilton; D S Alberts Journal: Cancer Res Date: 1999-10-15 Impact factor: 12.701
Authors: P Yang; J M Cunningham; K C Halling; T G Lesnick; L J Burgart; E M Wiegert; E R Christensen; N M Lindor; J A Katzmann; S N Thibodeau Journal: Mol Genet Metab Date: 2000-12 Impact factor: 4.797
Authors: M L Slattery; K Curtin; K Anderson; K N Ma; L Ballard; S Edwards; D Schaffer; J Potter; M Leppert; W S Samowitz Journal: J Natl Cancer Inst Date: 2000-11-15 Impact factor: 13.506
Authors: Paul Lochhead; Andrew T Chan; Reiko Nishihara; Charles S Fuchs; Andrew H Beck; Edward Giovannucci; Shuji Ogino Journal: Mod Pathol Date: 2014-06-13 Impact factor: 7.842
Authors: Wilson I Gonsalves; Michelle R Mahoney; Daniel J Sargent; Garth D Nelson; Steven R Alberts; Frank A Sinicrope; Richard M Goldberg; Paul J Limburg; Stephen N Thibodeau; Axel Grothey; Joleen M Hubbard; Emily Chan; Suresh Nair; Jeffrey L Berenberg; Robert R McWilliams Journal: J Natl Cancer Inst Date: 2014-06-12 Impact factor: 13.506
Authors: Amanda I Phipps; Qian Shi; Polly A Newcomb; Garth D Nelson; Daniel J Sargent; Steven R Alberts; Paul J Limburg Journal: J Clin Oncol Date: 2013-04-01 Impact factor: 44.544
Authors: Sean F Altekruse; Gabriel E Rosenfeld; Danielle M Carrick; Emilee J Pressman; Sheri D Schully; Leah E Mechanic; Kathleen A Cronin; Brenda Y Hernandez; Charles F Lynch; Wendy Cozen; Muin J Khoury; Lynne T Penberthy Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-12 Impact factor: 4.254
Authors: Lori S Tillmans; Robert A Vierkant; Alice H Wang; Niloy Jewel Samadder; Charles F Lynch; Kristin E Anderson; Amy J French; Robert W Haile; Lisa J Harnack; John D Potter; Susan L Slager; Thomas C Smyrk; Stephen N Thibodeau; James R Cerhan; Paul J Limburg Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-02-03 Impact factor: 4.254
Authors: Anthony A Razzak; Amy S Oxentenko; Robert A Vierkant; Lori S Tillmans; Alice H Wang; Daniel J Weisenberger; Peter W Laird; Charles F Lynch; Kristin E Anderson; Amy J French; Robert W Haile; Lisa J Harnack; John D Potter; Susan L Slager; Thomas C Smyrk; Stephen N Thibodeau; James R Cerhan; Paul J Limburg Journal: Nutr Cancer Date: 2012 Impact factor: 2.900
Authors: Lori S Tillmans; Robert A Vierkant; Alice H Wang; N Jewel Samadder; Charles F Lynch; Kristin E Anderson; Amy J French; Robert W Haile; Lisa J Harnack; John D Potter; Susan L Slager; Thomas C Smyrk; Stephen N Thibodeau; James R Cerhan; Paul J Limburg Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-12-16 Impact factor: 4.254
Authors: N Jewel Samadder; Robert A Vierkant; Lori S Tillmans; Alice H Wang; Daniel J Weisenberger; Peter W Laird; Charles F Lynch; Kristin E Anderson; Amy J French; Robert W Haile; John D Potter; Susan L Slager; Thomas C Smyrk; Stephen N Thibodeau; James R Cerhan; Paul J Limburg Journal: Gastroenterology Date: 2013-05-07 Impact factor: 22.682